SEARCH

SEARCH BY CITATION

References

  • 1
    Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci USA. 2006; 103: 564451.
  • 2
    Hsiung G-YR, Sadovnick AD, Feldman H. Apolipoprotein E-e4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging. CMAJ. 2004; 17: 8637.
  • 3
    Song Y, Stampfer MJ, Liu S. Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med. 2004; 141: 13747.
  • 4
    Licastro F, Chiappelli M, Caldarera CM, Tampieri C, Nanni S, Gallina M, Branzi A. The concomitant presence of polymorphic alleles of interleukin-1beta, interleukin-6 and apolipoprotein E is associated with an increased risk of myocardial infarction in elderly men. Results from a pilot study. Mech Ageing Dev. 2004; 5: 5759.
  • 5
    Sudlow C, Martinez Gonzalez NA, Kim J, Clark C. Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17,965 controls. Stroke. 2006; 37: 36470.
  • 6
    Ewbank DC. Differences in the association between apolipoprotein E genotype and mortality across populations. J Gerontol A Biol Sci Med Sci. 2007; 62: 899907.
  • 7
    Gerdes LU, Jeune B, Ranberg KA, Nybo H, Vaupel JW. Estimation of Apolipoprotein E genotype-specific relative mortality risks from the distribution of genotypes in centenarians and middle aged men: apolipoprotein E gene is a “frailty gene,” not a “longevity gene.” Genet Epidemiol. 2000; 19: 20210.
  • 8
    Bergman H, Ferrucci L, Guralnik J, Hogan DB, Hummel S, Karunananthan S, Wolfson C. Frailty: an emerging research and clinical paradigm issues and controversies. J Gerontol A Biol Sci Med Sci. 2007; 62: 7317.
  • 9
    Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, Mitnitski A. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005; 174: 48995.
  • 10
    Walston J, Hadley EC, Ferrucci L, Guralnik JM, Newman AB, Studenski SA, Ershler WB, Harris T, Fried LP. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc. 2006; 54: 9911001.
  • 11
    Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA; Cardiovascular Health Study Collaborative Research Group. Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001; 56: M14656.
  • 12
    Mitnitski AB, Mogilner AJ, Rockwood K. Accumulation of deficits as a proxy measure of aging. Sci World J. 2001; 1: 32336.
  • 13
    Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci. 2007; 62: 7227.
  • 14
    Rockwood K, Andrew MK, Mitnitski A. A comparison of two approaches to measuring frailty in elderly people. J Gerontol A Biol Sci Med Sci. 2007; 62: 73843.
  • 15
    Canadian Study of Health and Aging: study methods and prevalence of dementia, 1994. CMAJ. 1994; 150: 899913.
  • 16
    Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry. 1987; 48: 3148.
  • 17
    Graham JE, Rockwood K, Beattie BL, McDowell I, Eastwood R, Gauthier S. Standardization of the diagnosis of dementia in the Canadian Study of Health and Aging. Neuroepidemiology. 1996; 15: 24656.
  • 18
    American Psychiatric Association. Diagnostic and statistical manual. 3rded., rev. Washington : APA Press; 1987.
  • 19
    Ebly EM, Hogan DB, Parhad IM. Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging. Arch Neurol. 1995; 52: 6129.
  • 20
    Mitnitski AB, Song X, Skoog I, Broe GA, Cox JL, Grunfeld E, Rockwood K. Relative fitness and frailty of elderly men and women in developed countries and their relationship with mortality. J Am Geriatr Soc. 2005; 53: 21849.
  • 21
    Goggins WB, Woo J, Sham A, Ho SC. Frailty index as a measure of personal biological age in a Chinese population. J Gerontol A Biol Sci Med Sc. 2005; 60: 104651.
  • 22
    Kulminski AM, Ukraintseva SV, Akushevich IV, Arbeev KG, Yashin AI. Cumulative index of health deficiencies as a characteristic of long life. J Am Geriatr Soc. 2007; 55: 93540.
  • 23
    Rockwood K, Abeysundera M, Mitnitski A. How should we grade frailty in nursing home patients? J Am Med Dir Assoc. 2007; 8: 595603.
  • 24
    Gill TM, Gahbauer EA, Allore HG, Han L. Transitions between frailty states among community-living older persons. Arch Intern Med. 2006; 166: 41823.
  • 25
    Bandeen-Roche K, Xue QL, Ferrucci L, Walston J, Guralnik JM, Chaves P, Zeger SL, Fried LP. Phenotype of frailty: characterization in the women's health and aging studies. J Gerontol A Biol Sci Med Sci. 2006; 61: 2626.
  • 26
    Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991; 39: 1428.
  • 27
    Lindsay J, Laurin D, Verreault R. Risk factors for Alzheimer's disease: a prospective study from the Canadian Study of Health and Aging. Am J Epidemiol. 2002; 156: 44553.
  • 28
    McLeod DA, Arnott B, Gaudereault N, Boudreau S, Sevigny P. A comparison of two methods for routine, accurate determination of apolipoprotein E genotypes. Alzheimer's Rep. 1998; 1: 2115.
  • 29
    Zivelin A, Rosenberg N, Peretz H, Amit Y, Kornbrot N, Seligsohn U. Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes. Clin Chem. 1997; 43: 16579.
  • 30
    Kryscio RJ, Schmitt FA, Salazar JC, Mendiondo MS, Markesbery WR. Risk factors for transitions from normal to mild cognitive impairment and dementia. Neurology. 2006; 66: 82832.
  • 31
    Tyas SL, Salazar JC, Snowdon DA, Desrosiers MF, Riley KP, Mendiondo MS, Kryscio RJ. Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study. Am J Epidemiol. 2007; 165: 12318.
  • 32
    Bathum L, Christiansen L, Jeune B, Vaupel J, McGue M, Christensen K. Apolipoprotein E genotypes: relationship to cognitive functioning, cognitive decline, and survival in nonagenarians. J Am Ger Soc. 2006; 54: 6548.
  • 33
    Hayden KM, Zandi PP, Lyketsos CG, Tschanz JT, Norton MC, Khachaturian AS, Pieper CF, Welsh-Bohmer KA, Breitner JC; Cache County Investigators. Apolipoprotein E genotype and mortality: findings from the Cache County Study. J Am Geriatr Soc. 2005; 53: 93542.
  • 34
    Yashin AI, Ukraintseva SV, De Benedictis G, Anisimov VN, Butov AA, Arbeev K, Jdanov DA, Boiko SI, Begun AS, Bonafe M, Franceschi C. Have the oldest old adults ever been frail in the past? A hypothesis that explains modern trends in survival. J. Gerontol. A Biol Sci Med Sci. 2001; 56: B43242.
  • 35
    Kulminski AM, Ukraintseva SV, Yashin AI. The apolipoprotein E epsilon2 allele and aging-associated health deterioration in older males. J Am Geriatr Soc. 2007; 55: 147980.
  • 36
    Melzer D, Dik MG, van Kamp GJ, Jonker C, Deeg DJ. The Apolipoprotein E e4 polymorphism is strongly associated with poor mobility performance test results but not self-reported limitation in older people. J Gerontol A Biol Sci Med Sci. 2005; 60: 131923.
  • 37
    Panza F, D’Introno A, Colacicco  , Capurso C, Capurso S, Kehoe PG, Capurso A, Solfrizzi V. Vascular genetic factors and human longevity. Mech Ageing Dev. 2004; 125: 16978.
  • 38
    Stakias N, Liakos P, Tsiapali E, Goutou M, Koukoulis GN. Lower prevalence of epsilon 4 allele of apolipoprotein E gene in healthy, longer-lived individuals of Hellenic origin. J Gerontol A Biol Sci Med Sci. 2006; 61: 122831.
  • 39
    Stessman J, Maaravi Y, Hammerman-Rozenberg R, Cohen A, Nemanov L, Gritsenko I, Gruberman N, Ebstein RP. Candidate genes associated with ageing and life expectancy in the Jerusalem longitudinal study. Mech Ageing Dev. 2005; 126: 3339.
  • 40
    Nassar BA, Rockwood K, Kikrland SA, Ransom TP, Darvesh S, MacPherson K, Johnstone DE, O’Neill BJ, Bata IR, Andreou P, Jeffery JS, Cox JL, Title LM. Improved prediction of early-onset coronary artery disease using APOE ɛ4, BChE-K, PPARγ2 Pro12 and ENOS T-786C in a polygenic model. Clin Biochem. 2006; 39: 10914.